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c o r r e s p o n d e n c e
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
Arthroscopic Partial Meniscectomy for Degenerative  
Meniscal Tear
To the Editor: Previous studies have suggested 
that partial meniscectomy has little benefit in 
patients with advanced osteoarthritis1,2 but some 
benefit in those with mild-to-moderate osteoar-
thritis.3 Sihvonen and colleagues (Dec. 26 issue)4 
attempted to assess the benefit of partial menis-
cectomy in patients without osteoarthritis.
However, although the authors excluded pa-
tients with radiographic degenerative changes, 
the declaration of “no knee osteoarthritis” is mis-
leading. It is important to note that patients in 
this study did have cartilage degeneration. In fact, 
80% of the patients in the partial-meniscectomy 
group and 67% of those in the sham group had 
degenerative or osteoarthritic changes on diag-
nostic arthroscopy. In addition, patients with 
traumatic tears or mechanical symptoms were 
excluded, yet this is probably the group that 
would benefit most from arthroscopic partial 
meniscectomy.5 Lastly, magnetic resonance im-
aging (MRI) was not used to exclude or stratify 
patients according to factors such as subchon-
dral edema or chondromalacia.
We submit that arthroscopy remains an effec-
tive treatment for meniscal tears in selected pa-
tients. Surgical decision making should be indi-
vidualized, including consideration of mechanical 
symptoms, degenerative versus traumatic menis-
cal tear, and other pain generators, including 
the degree of arthritis.
Aaron J. Krych, M.D. 
Michael J. Stuart, M.D. 
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To the Editor: The Finnish Degenerative Menis-
cal Lesion Study (FIDELITY) Group conducted a 
surgical prospective, blinded, randomized trial. 
Their data are persuasive that the combination of 
knee pain and a meniscal tear confirmed on MRI 
does not warrant an arthroscopic partial meniscec-
tomy. It would be a mistake, however, to extrapo-
late a conclusion that partial meniscectomy is inap-
propriate for all patients with degenerative tears.
Mechanical symptoms are an important pri-
mary problem that arthroscopic meniscectomy 
can alleviate. Such symptoms were reported by 
less than half the patients in this study, and a 
locked knee was an exclusion criterion, according 
to data in the Supplementary Appendix (avail-
able with the full text of the article at NEJM.org).
The American Academy of Orthopaedic Sur-
geons (AAOS) has recently created appropriate-
use criteria for osteoarthritis of the knee.1 Rather 
than MRI evidence, mechanical symptoms were 
the trigger for recommendations for arthroscop-
ic meniscectomy. The appropriate-use criteria, in 
which a high level of appropriateness was given 
for arthroscopy, conflict with the results of this 
study. We hope future studies will address the 
important role of mechanical symptoms.
David S. Jevsevar, M.D., M.B.A.
Intermountain Zion Orthopaedics and Sports Medicine 
St. George, UT 
david.jevsevar@imail.org
Adolph J. Yates, Jr., M.D.
University of Pittsburgh School of Medicine 
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James O. Sanders, M.D.
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To the Editor: We are concerned that the study 
by Sihvonen and colleagues will be interpreted by 
many to indicate that surgery for a meniscal tear 
does not work. However, five study sites required 
more than 5 years to enroll 205 patients. The 
authors did not provide the numbers of patients 
who did not meet the inclusion criteria but still 
received medial (not lateral) meniscectomies. 
Also, both treatment groups had meaningful im-
provements; we believe this may be explained by 
the nature of the sham control — not a true 
sham, but arthroscopic lavage, which is an ac-
cepted surgical procedure. The study did not ex-
amine whether arthroscopic partial meniscec-
tomy is effective but whether it is more effective 
than arthroscopic lavage without arthroscopic 
partial meniscectomy. Given the diagnostic dif-
ficulty in distinguishing between degenerative 
and acute meniscal tears clinically, as well as the 
low generalizability of the findings, the authors’ 
conclusions that “these results argue against the 
current practice of performing arthroscopic par-
tial meniscectomy in patients with degenerative 
meniscal tear” is too broad.
Christian Lattermann, M.D.
University of Kentucky 
Lexington, KY 
clatt2@uky.edu
Andreas H. Gomoll, M.D.
Brigham and Women’s Hospital 
Boston, MA
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Midwest Orthopaedics at Rush University 
Chicago, IL
No potential conflict of interest relevant to this letter was re-
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DOI: 10.1056/NEJMc1401128
The Authors Reply: Krych et al. point out that the 
majority of patients in our trial had cartilage de-
generation on arthroscopy. However, we disagree 
that our description of “no knee osteoarthritis” 
was misleading, since arthroscopically determined 
cartilage degeneration is not considered osteoar-
thritis by any currently used clinical criteria.
We also disagree with the notion that pa-
tients with traumatic tears or mechanical symp-
toms were excluded from our trial. Although true 
traumatic onset of symptoms was an exclusion 
criterion, in 16% of our patients the onset was 
sudden or after twisting, and 47% had preopera-
tive mechanical symptoms. We are aware that 
such patients are widely considered to be the 
group most likely to benefit from arthroscopic 
partial meniscectomy. Krych et al. refer to a re-
cent survey evaluating clinical decision making 
for arthroscopic partial meniscectomy among 
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practicing orthopedic surgeons, in which me-
chanical symptoms were not even included ow-
ing to the presumption that they would be unani-
mously considered a definite surgical indication. 
As noted by Jevsevar et al., the AAOS shares this 
stance.1 However, compelling evidence is lacking 
to support the assumption that mechanical symp-
toms are caused by degenerative meniscal tears 
or that they can be alleviated by arthroscopic 
partial meniscectomy in these patients.
Krych et al. state that subchondral edema and 
chondromalacia could affect the outcome of ar-
throscopic partial meniscectomy. Although this 
is possible, to our knowledge, no conclusive evi-
dence exists to support such assumptions in this 
particular patient population. Reliable testing of 
hypotheses like these would require that criteria 
for these potential prognostic factors first be 
accepted and validated.
In response to Lattermann et al.: we empha-
size that FIDELITY was designed as an efficacy 
(proof-of-concept) trial with the intention of re-
cruiting not typical patients undergoing arthro-
scopic partial meniscectomy but rather patients 
most likely to have a good response (those with 
a medial meniscal tear but no osteoarthritis). 
This also explains the lengthy recruitment period 
despite the participation of five high-volume 
centers. Although the study design has been 
elaborated in detail previously,2 we briefly note 
that an efficacy trial assesses whether an inter-
vention — here, arthroscopic partial meniscec-
tomy — can theoretically work under the best 
circumstances. If the results are negative, this 
suggests that it is not necessary to assess effec-
tiveness in less optimal, routine settings.3 With 
respect to the concern that lavage was not an 
appropriate control, the existing high-quality 
evidence is unambiguous: tidal irrigation4 and 
arthroscopic lavage5 have failed to provide a 
benefit over sham procedures (sham irrigation 
and skin incisions, respectively) in randomized 
trials involving patients with osteoarthritis. The 
AAOS seems to endorse this view.1
Teppo L.N. Järvinen, M.D., Ph.D.
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Abatacept in B7-1–Positive Proteinuric Kidney Disease
To the Editor: In their Brief Report, Yu et al. 
(Dec. 19 issue)1 describe the use of abatacept, an 
inhibitor of the T-cell costimulatory molecule 
B7-1, in inducing remission in five patients with 
focal segmental glomerulosclerosis (FSGS) resis-
tant to rituximab and glucocorticoids (one patient 
with primary FSGS and four with recurrent FSGS 
after transplantation). The rationale for using 
abatacept was that B7-1 is induced in podocytes 
in primary and recurrent FSGS as well as in pa-
tients with membranous nephropathy.
In an attempt to reproduce their findings 
with the same antibodies, we found no B7-1 
signal in samples obtained from patients with 
recurrent FSGS after transplantation and strong 
staining in samples obtained from patients with 
membranous nephropathy, results almost identi-
cal to those reported by Yu et al. However, sec-
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